Genetics
Home › Medical research › Appetite loss / anorexia
Limited evidence

Appetite loss / anorexia & cannabis

The clearest benefit is dronabinol (synthetic THC) for AIDS-related appetite loss (FDA-approved). Outside AIDS, evidence for appetite stimulation is limited, and high-quality trials in cancer cachexia were negative.

Sources: Dronabinol label (FDA) · Cachexia trial (Jatoi 2002, JCO)

Most-studied cannabinoids

THC

Safety & cautions

Largely AIDS-specific; not a general appetite cure.

Clinical research below concerns cannabis or cannabinoids, not evidence that a named cultivar treats a condition.

Help us build this responsibly

This page reflects the cited published clinical evidence, and it is a work in progress. Areto is committed to expanding and refining it as new research emerges — so it can genuinely help medical patients make informed choices. If you are a clinician, researcher, or patient with peer-reviewed sources to add, email us at genetics@areto.tech.

Areto Genetics is an educational cannabis catalog. Nothing here is medical advice, and no strain is proven to treat, cure, or prevent any disease. Cannabis affects people differently and carries real risks. Talk to a qualified healthcare provider before using cannabis for any condition — especially if you are pregnant or breastfeeding, an adolescent, taking other medications, or have a heart, liver, or psychiatric condition.